|
[1]
|
Jemal, A., Siegel, R., Xu, J., et al. (2010) Cancer Statistics, 2010. CA: A Cancer Journal for Clinicians, 60, 277-300.
|
|
[2]
|
Jendrzejewski, J., Thomas, A., Liyanarachchi, S., et al. (2015) PTCSC3 Is Involved in Papillary Thyroid Carcinoma Development by Modulating S100A4 Gene Expression. The Journal of Clinical Endocrinology & Metabo-lism, 100, E1370-E1377. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
滕理送, 许泽杭, 王伟斌. 碘难治性分化型甲状腺癌靶向治疗新进展[J]. 肿瘤防治研究, 2023, 50(5): 452-457.
|
|
[4]
|
Karapanou, O., Simeakis, G., Vlassopoulou, B., et al. (2022) Advanced RAI-Refractory Thyroid Cancer: An Update on Treatment Perspectives. Endocrine-Related Cancer, 29, R57-R66. [Google Scholar] [CrossRef]
|
|
[5]
|
李艳娜, 王智雄, 曹丹萍, 等. 长链非编码RNA CASC10在胃癌中的表达及对胃癌细胞增殖、迁移和侵袭的影响[J]. 皖南医学院学报, 2023, 42(4): 307-311.
|
|
[6]
|
崔鹤, 居晓斌, 叶琴, 潘猛, 周惠英. 长链非编码RNA BANCR在胃癌中表达及其对胃癌细胞迁移、侵袭的影响[J]. 南京医科大学学报(自然科学版), 2018, 38(12): 1674-1678.
|
|
[7]
|
Wang, Y., Guo, Q., Zhao, Y., et al. (2014) BRAF Activated Long Non Coding RNA Contributes to Cell Proliferation and Activates Autophagy in Pa-pillary Thyroid Carcinoma. Oncology Letters, 8, 1947-1952. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
唐建东, 栗夏莲. 甲状腺乳头状癌组织中TSHR基因启动子甲基化研究[J]. 医学研究杂志, 2010, 39(4): 77-79.
|
|
[9]
|
田文, 郗洪庆. 甲状腺癌病人生存现状分析[J]. 中国实用外科杂志, 2016, 36(5): 489-493.
|
|
[10]
|
季振华, 蒋斌, 陈卫贤, 等. 男性甲状腺乳头状癌临床病理特征及颈淋巴结转移危险因素分析[J]. 中国眼耳鼻喉科杂志, 2023, 23(4): 293-297.
|
|
[11]
|
So, Y.K., Kim, M.J., Kim, S., et al. (2018) Lateral Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis for Prevalence, Risk Factors, and Location. International Journal of Surgery, 50, 94-103. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
杜静海, 陈春悠, 郭欣, 等. BTG3在甲状腺乳头状癌组织中的表达及其对细胞增殖、侵袭、迁移的影响[J]. 东南大学学报: 医学版, 2019, 38(6): 984-988.
|
|
[13]
|
Moulana, F.I., Priyani, A.A.H., de Silva, M.V.C., et al. (2018) BRAF-Oncogene Induced Senescence and the Role of Thyroid-Stimulating Hormone Signaling in the Progression of Pa-pillary Thyroid Carcinoma. Hormones & Cancer, 9, 1-11. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Sun, Y., Shi, C.L., Shi, T.F., et al. (2015) Correlation between the BRAFv600E Gene Mutation and Factors Influencing the Prognosis of Papillary Thyroid Microcarcinoma. International Journal of Clinical and Experimental Medicine, 8, 22525-22528.
|
|
[15]
|
Wang, Z., Chen, J.Q., Liu, J.L., et al. (2016) Clinical Impact of BRAF Mutation on the Diagnosis and Prognosis of Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis. European Journal of Clinical Investigation, 46, 146-157. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Chen, Y.F., Sadow, P.M., Suh, H., et al. (2016) BRAFV600E Is Correlated with Recurrence of Papillary Thyroid Microcarcinoma: A Systematic Review, Mul-ti-Institutional Primary Data Analysis, and Meta-Analysis. Thyroid, 26, 248-255. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
刘文, 程若川, 苏艳军, 等. 2015版美国甲状腺协会指南cN0甲状腺乳头状癌手术方案合理性分析[J]. 中国实用外科杂志, 2017, 37(5): 568-571.
|
|
[18]
|
黄颖, 曾繁余, 杜勇, 等. 多灶性甲状腺乳头状癌颈部中央区淋巴结转移危险因素分析[J]. 中文科技期刊数据库(全文版)医药卫生, 2023(8): 50-53.
|
|
[19]
|
许敬, 郭新海, 葛明华. 甲状腺乳头状癌中TSHR与NIS基因启动子区甲基化状态与侵袭性相关性研究[J]. 中国现代医生, 2016(21): 1-5.
|
|
[20]
|
Stephen, J.K., Chen, K.M., Merritt, J., et al. (2018) Methylation Markers Differentiate Thyroid Cancer from Benign Nodules. Journal of Endocrinological Investigation, 41, 163-170. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Smith, J.A., Fan, C.Y., Zou, C., et al. (2007) Methylation Status of Genes in Papillary Thyroid Carcinoma. Archives of Otolaryngology—Head & Neck Surgery, 133, 1006-1011. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Xing, M., Usadel, H., Cohen, Y., et al. (2003) Methylation of the Thyroid-Stimulating Hormone Receptor Gene in Epithelial Thyroid Tumors: A Marker of Malignancy and a Cause of Gene Silencing. Cancer Research, 63, 2316-2321.
|
|
[23]
|
Feng, F., Wang, H., Hou, S., et al. (2012) Re-Induction of Cell Differentiation and (131)I Uptake in Dedifferentiated FTC-133 Cell Line by TSHR Gene Transfection. Nuclear Medicine and Biology, 39, 1261-1265. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Liao, T., Qu, N., Shi, R.L., et al. (2017) BRAF-Activated LncRNA Functions as a Tumor Suppressor in Papillary Thyroid Cancer. Oncotarget, 8, 238-247. [Google Scholar] [CrossRef] [PubMed]
|